Joel R. Saper

Botulinum Toxin Type A as a Migraine Preventive Treatment

Stephen D. Silberstein, Ninan T. Mathew, Joel R. Saper et al. · Headache The Journal of Head and Face Pain · 2000 · 542 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Stephen D. Silberstein, Richard B. Lipton, David W. Dodick et al. · Headache The Journal of Head and Face Pain · 2007 · 503 citations

Pharmacy, Neurology, Pharmacotherapy +14

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Richard B. Lipton, David W. Dodick, Stephen D. Silberstein et al. · The Lancet Neurology · 2010 · 464 citations

Life Sciences, Neurology, Neuroscience +10

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

Joel R. Saper, David W. Dodick, Stephen D. Silberstein et al. · Cephalalgia · 2010 · 426 citations · Full text

Medicine, Neurology, Pain Management +14

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Messoud Ashina, Joel R. Saper, Roger Cady et al. · Cephalalgia · 2020 · 397 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15